This partnership meshes with OBT’s hybrid partnership-pipeline strategy, which prioritises collaboration to extend its market ...
MultiTech Systems, a leading provider of IoT devices and connectivity solutions, today announced the unveiling of the MultiTech Niagara Driver ("the Niagara Driver") at the Tridium Niagara Summit, ...
After several years of turning out solid growth, Bristol Myers Squibb knows it’s nearing a patent cliff that’ll wreak havoc later this decade. Still, the company believes a “diversified” ...
Bristol Myers Squibb (BMS) plans to buy out its partner in developing the blockbuster multiple myeloma drug Abecma ® (idecabtagene vicleucel), by agreeing to acquire 2seventy bio for approximately ...
Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results